SCHEMBL3601476

SCHEMBL3601476

C=CC(Cl)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.46
CYP17A1 P05093 1/20 0.44
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
CYP1A2 P05177 1/20 0.41
ACP3 P15309 2/20 0.39
PTGS2 P35354 2/20 0.39
ALDH1A1 P00352 2/20 0.39
OPRD1 P41143 1/20 0.39
TSHR P16473 1/20 0.37
ESR2 Q92731 1/20 0.36
MAPK1 P28482 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MMP3 P08254 1/20 0.36
BCL2L1 Q07817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28136546 0.86 TSHR (0.50) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
SCHEMBL109223 0.86 TSHR (0.50) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
SCHEMBL30724553 0.84 TSHR (0.48) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
Ethylene SCHEMBL27607233 0.84 TSHR (0.48) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
Ammonia Solution, Strong SCHEMBL9691228 0.84 TSHR (0.48) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
Hydrochloric Acid SCHEMBL11666238 0.84 TSHR (0.48) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
Butadiene SCHEMBL11004598 0.82 TSHR (0.46) CYP3A4ALDH1A1TSHRTAAR1HSD17B10
SCHEMBL3791852 0.78 ACP3 (0.44) CYP3A4CHRNB2CHRNA4CYP1A2ACP3
1,1-Dichloroethene SCHEMBL17353950 0.78 TSHR (0.42) CYP3A4ALDH1A1TSHRMAPK1HSD17B10
Trimethylammonium SCHEMBL4188940 0.78 TSHR (0.42) CYP3A4ALDH1A1TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674825-B2 Dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2010-03-09 US disclosed
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties PC, GOT2, SDHA CYP3A4 349/4885CYP17A1 1464/4885CHRNB2 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.